Cargando...
Improving the Angiogenic Potential of EPCs via Engineering with Synthetic Modified mRNAs
The application of endothelial progenitor cells (EPCs) for the revascularization of ischemic tissues, such as after myocardial infarction, stroke, and acute limb ischemia, has a huge clinical potential. However, the low retention and engraftment of EPCs as well as the poor survival of migrated stem...
Guardado en:
| Publicado en: | Mol Ther Nucleic Acids |
|---|---|
| Autores principales: | , , , , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
American Society of Gene & Cell Therapy
2018
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6198099/ https://ncbi.nlm.nih.gov/pubmed/30343252 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.omtn.2018.09.005 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|